How many employees does SELLAS Life Sciences Group, Inc. have?

SELLAS Life Sciences Group, Inc. reported 17 employees for the fiscal year ending Dec 2022, in the annual report it filed on March 16, 2023. That is up 54.5% from a year earlier.

What is SELLAS Life Sciences Group, Inc.'s revenue per employee?

SELLAS Life Sciences Group, Inc. brought in $1.0M of revenue in fiscal Dec 2022, which is $59K per employee. That ranks 38 of 40 companies we track in Biotechnology, where the median is $574K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

SELLAS Life Sciences Group, Inc. employees and revenue per employee

SLS · Biotechnology · $1.91B market cap

SELLAS Life Sciences Group, Inc. had 17 employees at the end of fiscal Dec 2022, up 54.5% from a year earlier. Revenue for the year was $1.0M, down 86.8% from a year earlier, or $59K per employee. Revenue fell while headcount grew.

The latest annual report we hold is more than two years old, so these numbers may be out of date.

Employees

+54.5% YoY

Revenue

$1.0M

-86.8% YoY

Revenue / employee

$59K

Peer median $574K

Rank in industry

38 of 40

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2020

Hover a year for the numbers.

SLS employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2022	17	$1.0M	$59K	+54.5%	-86.8%
Dec 2021	11	$7.6M	$691K	+57.1%	+300.0%
Dec 2020	7	$1.9M	$271K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

SELLAS Life Sciences Group, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
PTGX Protagonist Therapeutics, Inc.	132	$46.0M	$349K	Hiring into decline
NUVB Nuvation Bio Inc.	298	$62.9M	$211K	Efficient growth
KYMR Kymera Therapeutics, Inc.	238	$39.2M	$165K	Hiring into decline
RLAY Relay Therapeutics, Inc.	192	$15.4M	$80K	Leaner
PRAX Praxis Precision Medicines, Inc.	116	$8.6M	$74K	Efficient growth
PGEN Precigen, Inc.	160	$9.7M	$61K	Efficient growth
SLS SELLAS Life Sciences Group, Inc.	17	$1.0M	$59K	Hiring into decline
IMNM Immunome, Inc.	177	$6.9M	$39K	Hiring into decline
CRNX Crinetics Pharmaceuticals, Inc.	594	$7.7M	$13K	Efficient growth

Every Healthcare company

Questions about SELLAS Life Sciences Group, Inc.

How many employees does SELLAS Life Sciences Group, Inc. have?: SELLAS Life Sciences Group, Inc. reported 17 employees for the fiscal year ending Dec 2022, in the annual report it filed on March 16, 2023. That is up 54.5% from a year earlier.
What is SELLAS Life Sciences Group, Inc.'s revenue per employee?: SELLAS Life Sciences Group, Inc. brought in $1.0M of revenue in fiscal Dec 2022, which is $59K per employee. That ranks 38 of 40 companies we track in Biotechnology, where the median is $574K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare SLS with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in SELLAS Life Sciences Group, Inc.'s annual reports (Form 10-K), latest filed March 16, 2023. This is data, not a recommendation to buy or sell SLS.